The first patient developed undatable atrial fibrillation, which was resistant to pharmacological treatment and electrical cardioversion.
R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini 2016, 'Possible relationship between certolizumab pegol and arrhythmias: report of two cases',Reumatismohttp://www.reumatismo.org/index.php/reuma/article/view/869. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)